nilotinib

Spain

Drugs containing this active substance

  • NILOTINIB ACCORD 150 MG HARD CAPSULES EFG

    It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either upon new diagnosis or when other treatments have not worked or have caused serious side effects.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 150 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a first-line treatment or when other medicines have not worked or have caused serious side effects.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 200 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 50 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either in newly diagnosed patients or in those who have not responded to previous treatments.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 200 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Zentiva K.S.

  • It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either upon new diagnosis or when other treatments have not worked or have caused serious side effects.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 150 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Novartis Europharm Limited

  • It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.

    Form: capsules, hard

    Active substance Dosage
    nilotinib 200 mg

    ATC: L01E L01EA L01EA03

    Manufacturer: Novartis Europharm Limited